Abiopharma

🔍 Baack Jerry J. (Executive)

Company: Bridgewater Bancshares Inc (BWB)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 10,000 shares of Common Stock at $22.0282 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,148,769.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 15,000 shares of Common Stock at $22.2146 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,133,769.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: H | nature_of_ownership: By dependent child | shares_owned_after: 1,000.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: H | nature_of_ownership: As custodian for child | shares_owned_after: 1,000.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: H | nature_of_ownership: As custodian for child | shares_owned_after: 1,000.00

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.11, inclusive. The reporting person undertakes to provide to Bridgewater Bancshares, Inc., any security holder of Bridgewater Bancshares, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in this footnote to this Form 4.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.10 to $22.30, inclusive. The reporting person undertakes to provide to Bridgewater Bancshares, Inc., any security holder of Bridgewater Bancshares, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in this footnote to this Form 4.